X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (209) 209
Book / eBook (65) 65
Newspaper Article (50) 50
Publication (25) 25
Conference Proceeding (18) 18
Patent (8) 8
Book Chapter (6) 6
Book Review (2) 2
Web Resource (2) 2
Magazine Article (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (107) 107
humans (85) 85
index medicus (83) 83
male (48) 48
chemotherapy (41) 41
female (37) 37
aged (31) 31
lung neoplasms - drug therapy (31) 31
respiratory system (31) 31
middle aged (30) 30
cancer (29) 29
lung neoplasms - pathology (29) 29
adult (27) 27
lung cancer, non-small cell (26) 26
lung cancer (25) 25
carcinoma, non-small-cell lung - drug therapy (24) 24
cell lung-cancer (21) 21
carcinoma, non-small-cell lung - pathology (20) 20
surgery (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
treatment outcome (19) 19
hematology, oncology and palliative medicine (17) 17
lung neoplasms - genetics (17) 17
neoplasm staging (17) 17
open-label (17) 17
lung neoplasms - therapy (16) 16
survival (16) 16
history (15) 15
mutation (15) 15
care and treatment (14) 14
immunotherapy (14) 14
patients (14) 14
radiotherapy (14) 14
aged, 80 and over (13) 13
carcinoma, non-small-cell lung - therapy (13) 13
crizotinib (13) 13
lung neoplasms - diagnosis (13) 13
tumors (13) 13
animals (12) 12
carcinoma, non-small-cell lung - genetics (12) 12
nsclc (12) 12
phase-ii trial (12) 12
research (12) 12
antineoplastic agents - therapeutic use (11) 11
metastasis (11) 11
adenocarcinoma (10) 10
analysis (10) 10
history and criticism (10) 10
non-small-cell lung cancer (10) 10
therapy (10) 10
biopsy (9) 9
cancer therapies (9) 9
carcinoma, non-small-cell lung - diagnosis (9) 9
cisplatin (9) 9
disease-free survival (9) 9
follow-up studies (9) 9
health aspects (9) 9
mutations (9) 9
non-small cell lung cancer (9) 9
abridged index medicus (8) 8
diagnosis (8) 8
drug therapy (8) 8
immunohistochemistry (8) 8
lung neoplasms - mortality (8) 8
non-small cell lung carcinoma (8) 8
patient outcomes (8) 8
prognosis (8) 8
protein kinase inhibitors - therapeutic use (8) 8
risk factors (8) 8
trial (8) 8
tyrosine kinase inhibitors (8) 8
1506 (7) 7
carcinoma (7) 7
combined modality therapy (7) 7
erlotinib (7) 7
esmo (7) 7
europe (7) 7
expression (7) 7
medicine, general & internal (7) 7
pneumonectomy (7) 7
pulmonary/respiratory (7) 7
retrospective studies (7) 7
survival analysis (7) 7
switzerland (7) 7
targeted therapy (7) 7
tomography, x-ray computed (7) 7
acquired-resistance (6) 6
adenocarcinoma - drug therapy (6) 6
adenocarcinoma of lung (6) 6
cohort studies (6) 6
disease progression (6) 6
docetaxel (6) 6
double-blind (6) 6
gefitinib (6) 6
germany (6) 6
growth-factor receptor (6) 6
lung cancer, small cell (6) 6
lung neoplasms - surgery (6) 6
molecular targeted therapy (6) 6
mortality (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (28) 28
Robarts - Stacks (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Art - Library use only (2) 2
Online Resources - Online (2) 2
UofT at Scarborough - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Music - Reference (1) 1
Robarts - Course Reserves (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015, ISBN 3319060627
This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been... 
Medicine | Thoracic surgery | Surgery | Oncology | Radiotherapy | Cancer
Web Resource
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii7.3 - vii7
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii40.1 - vii40
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9998, pp. 1049 - 1056
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Neuron, ISSN 0896-6273, 12/2015, Volume 88, Issue 5, pp. 902 - 909
A non-coding hexanucleotide repeat expansion in the gene is the most common mutation associated with familial amyotrophic lateral sclerosis (ALS) and... 
RAN translation | transgenic mice | Amyotrophic lateral sclerosis (ALS) | frontotemporal dementia (FTD) | neurodegeneration | microRNA | repeat expansions | C9ORF72 | RNA foci | Repeat expansions | MicroRNA | Neurodegeneration | Transgenic mice | Frontotemporal dementia (FTD) | DEMENTIA | ALS | AMYOTROPHIC-LATERAL-SCLEROSIS | SPECTRUM | MODEL | FRONTOTEMPORAL LOBAR DEGENERATION | TRANSLATION | SENSE | NEUROSCIENCES | PATHOLOGICAL FEATURES | Age Factors | Amyotrophic Lateral Sclerosis - physiopathology | DNA Repeat Expansion - genetics | Humans | MicroRNAs - metabolism | Frontotemporal Dementia - mortality | Cerebral Cortex - cytology | Brain - metabolism | Chromosomes, Artificial, Bacterial - genetics | Chromosomes, Artificial, Bacterial - metabolism | Neurons - physiology | C9orf72 Protein | Dipeptides - metabolism | Neurons - drug effects | Disease Models, Animal | Frontotemporal Dementia - pathology | Frontotemporal Dementia - genetics | Frontotemporal Dementia - physiopathology | Gene Expression Regulation - genetics | Amyotrophic Lateral Sclerosis - genetics | Cells, Cultured | Genotype | Mice, Transgenic | Amyotrophic Lateral Sclerosis - mortality | Nerve Tissue Proteins - metabolism | Proteins - genetics | Amyotrophic Lateral Sclerosis - pathology | Animals | Brain - pathology | In Vitro Techniques | Dipeptides - genetics | Proteins | Neurosciences | Proline | Genetic engineering | Glycine | Dementia | Analysis | Genetic translation | Plasmids | Neurons | Rodents | Cloning | Amyotrophic lateral sclerosis | Behavior | Artificial chromosomes | Expansion
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1986 - 1988
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 25, pp. 2415 - 2426
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1651 - 1658
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 16, pp. 1997 - 2003
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2014, Volume 3, Issue 2, pp. 84 - 88
HER2 mutations, largely exon 20 in-frame insertions, have been described as an oncogenic driver alteration in 1% to 4% of NSCLC, exclusively in adenocarcinoma... 
Dacomitinib | Afatinib | HER2 mutations | Irreversible pan HER-receptor inhibitor | Lung cancer | lung cancer | afatinib | Review | dacomitinib | irreversible pan HER-receptor inhibitor
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 7/2018, Volume 19, Issue 7, pp. 1 - 14
A decade after the discovery of echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (EML4-ALK) rearrangements in non-small cell... 
ALK | Alectinib | Oncology | Advanced non-small cell lung cancer | Medicine & Public Health | Resistance to crizotinib | TRANSFORMATION | SURVIVAL | EFFICACY | ALK-REARRANGED ADENOCARCINOMA | EML4-ALK FUSION GENE | OPEN-LABEL | CHEMOTHERAPY | CELL LUNG-CANCER | ONCOLOGY | CERITINIB | CRIZOTINIB | Usage | Lymphomas | Research | Drug therapy | Phosphotransferases | Risk factors
Journal Article